2025 Partners
SHINE
Exhibition Partner
SHINE is a next-generation nuclear technology company, focused on deploying state-of-the-art fusion technology to help solve global problems and create a scalable path toward practical fusion energy. SHINE deploys its safe, cost-effective and environmentally friendly technology in a step-wise approach, beginning with our systems used for advanced industrial imaging in non-destructive testing of components used in aerospace, defense, transportation, energy and other sectors. SHINE’s proprietary medical isotope production creates Molybdenum 99 and non-carrier added Lutetium 177 used in tens of thousands of daily procedures to diagnose and treat heart disease and late-stage cancer. For more information, follow SHINE on Facebook, LinkedIn and Twitter.
Northstar Medical Radioisotopes
Event Partner
NorthStar's Radiopharmaceutical CDMO/CMO unit offers customized services and expertise to accelerate biopharmaceutical companies' development and commercialization programs. The NorthStar CDMO is the first and only U.S. facility providing commercial-scale, multi-radioisotope production and radiopharmaceutical development on-site. With a 52,000 sq. ft. footprint, it sets new industry standards, serving the growing therapeutic and diagnostic radiopharmaceuticals market. Our facility effectively supports the entire product lifecycle, with cGMP and radiation safety programs to ensure high-quality and safe practices.